← back to search

Arshad M. Khanani

Regenxbio (United States) · US
🔎 Find collaborators in Ophthalmology · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Ophthalmology · Epidemiology
Research interest
Research interests include Retinal Diseases and Treatments, Ophthalmology and Visual Impairment Studies, Retinal Imaging and Analysis, and Ocular Diseases and Behçet’s Syndrome.
h-index
34
citations
5,092
works
163
NIH funding
primary concept
Macular degeneration
email

Recent publications

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
JAMA Ophthalmology 2025cited by 16position: firstdoi
Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema
NEJM Evidence 2025cited by 13position: middledoi
TENAYA and LUCERNE
Ophthalmology 2024cited by 161position: firstdoi
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy
Ophthalmology Retina 2024cited by 15position: middledoi
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE
Retina 2024cited by 10position: middledoi
Resolution of Angiographic Macular Leakage with Faricimab versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE
Ophthalmology Retina 2024cited by 9position: middledoi
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
The Lancet 2023cited by 420position: middledoi
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study
EClinicalMedicine 2023cited by 62position: firstdoi
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina 2023cited by 32position: middledoi
Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
Expert Opinion on Biological Therapy 2023cited by 26position: middledoi
Review of gene therapies for age-related macular degeneration
Eye 2022cited by 113position: firstdoi
Emerging Therapies in Neovascular Age-Related Macular Degeneration in 2020
Asia-Pacific Journal of Ophthalmology 2020cited by 80position: middledoi
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology Retina 2020cited by 74position: firstdoi
Purtscher's-like retinopathy associated with acute pancreatitis
American Journal of Ophthalmology Case Reports 2020cited by 16position: middledoi
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema
Ophthalmology 2019cited by 269position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charles C. Wykoff · Nune Eye Hospital4 papers (2019–2024)Carl D. Regillo · Thomas Jefferson University3 papers (2023–2025) · 3 papers (2022–2024)Aamir Aziz · University of Nevada, Reno3 papers (2020–2022)Peter K. Kaiser · Cleveland Clinic3 papers (2022–2024) · 2 papers (2020–2025)David S. Boyer · University of Southern California2 papers (2023–2024)Veeral Sheth · University of Illinois Chicago2 papers (2024–2025)Szilárd Kiss · Cornell University2 papers (2022–2023)Mark Barakat · University of Arizona2 papers (2023–2024)Glenn Yiu · University of California, Davis2 papers (2022–2024)Jeffrey S. Heier · Wills Eye Hospital2 papers (2023–2024)Thomas A. Ciulla · Indiana University School of Medicine1 papers (2024–2024) · 1 papers (2020–2020) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Hélène Karcher · Novartis (Switzerland)1 papers (2023–2023) · 1 papers (2025–2025) · 1 papers (2019–2019)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Ophthalmology · Epidemiology →